HDAC Antibodies

Santa Cruz Biotechnology features a diverse variety of HDAC monoclonal antibodies for research in epigenetics and gene regulation. HDAC Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Histone deacetylases (HDACs) play a crucial role in the regulation of gene expression by removing acetyl groups from histones, leading to chromatin condensation and transcriptional repression. Dysregulation of HDAC activity has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making HDACs significant targets for therapeutic intervention. Understanding HDAC function is essential for elucidating cellular processes and disease mechanisms. HDAC research continues to reveal new insights into epigenetic regulation and potential therapeutic approaches. Ongoing studies highlight the importance of precise HDAC detection and analysis in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of epigenetic regulation and its impact on human health.